These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Method for testing aseptic technique of intravenous admixture personnel. Dirks I; Smith FM; Furtado D; White SJ; Godwin HN Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641 [TBL] [Abstract][Full Text] [Related]
8. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom. Thomas M; Sanborn MD; Couldry R Am J Health Syst Pharm; 2005 Nov; 62(22):2386-92. PubMed ID: 16278330 [TBL] [Abstract][Full Text] [Related]
10. Cumulative sum control charts for admixture quality control. Sanford RL Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472 [TBL] [Abstract][Full Text] [Related]
11. Improved aseptic technique can reduce variable contamination rates of ward-prepared parenteral doses. Austin P; Elia M J Hosp Infect; 2013 Feb; 83(2):160-3. PubMed ID: 23313030 [TBL] [Abstract][Full Text] [Related]
12. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals. Crawford SY; Narducci WA; Augustine SC Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573 [TBL] [Abstract][Full Text] [Related]
13. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations. Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200 [TBL] [Abstract][Full Text] [Related]
14. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures. Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557 [TBL] [Abstract][Full Text] [Related]
15. A first-phase quality assurance program for intravenous admixture aseptic technique. Gurwich EL; Hanold L; Schaeffer P Hosp Pharm; 1982 Mar; 17(3):119-21. PubMed ID: 10255637 [TBL] [Abstract][Full Text] [Related]
16. Aseptic simulation test challenged with microorganisms for validation of pharmacy operators. Sigward E; Fourgeaud M; Vazquez R; Guerrault-Moro MN; Brossard D; Crauste-Manciet S Am J Health Syst Pharm; 2012 Jul; 69(14):1218-24. PubMed ID: 22761076 [TBL] [Abstract][Full Text] [Related]
18. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding. Trissel LA; Gentempo JA; Anderson RW; Lajeunesse JD Am J Health Syst Pharm; 2005 Feb; 62(3):285-8. PubMed ID: 15719586 [TBL] [Abstract][Full Text] [Related]
19. Assuring the quality of intravenous admixture programs. Stolar MH Am J Hosp Pharm; 1979 May; 36(5):605-8. PubMed ID: 453213 [TBL] [Abstract][Full Text] [Related]
20. Microbiologic quality assurance for intravenous admixtures in a small hospital. Doss HL; James JD; Killough DM; Snodgrass GL Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]